Academic Journal
Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough
Title: | Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough |
---|---|
Authors: | Rhianna E. Lee, Catherine A. Lewis, Lihua He, Emily C. Bulik-Sullivan, Samuel C. Gallant, Teresa M. Mascenik, Hong Dang, Deborah M. Cholon, Martina Gentzsch, Lisa C. Morton, John T. Minges, Jonathan W. Theile, Neil A. Castle, Michael R. Knowles, Adam J. Kimple, Scott H. Randell |
Source: | The Journal of Clinical Investigation, Vol 132, Iss 18 (2022) |
Publisher Information: | American Society for Clinical Investigation, 2022. |
Publication Year: | 2022 |
Collection: | LCC:Medicine |
Subject Terms: | Pulmonology, Therapeutics, Medicine |
More Details: | The vast majority of people with cystic fibrosis (CF) are now eligible for CF transmembrane regulator (CFTR) modulator therapy. The remaining individuals with CF harbor premature termination codons (PTCs) or rare CFTR variants with limited treatment options. Although the clinical modulator response can be reliably predicted using primary airway epithelial cells, primary cells carrying rare CFTR variants are scarce. To overcome this obstacle, cell lines can be created by overexpression of mouse Bmi-1 and human TERT (hTERT). Using this approach, we developed 2 non-CF and 6 CF airway epithelial cell lines, 3 of which were homozygous for the W1282X PTC variant. The Bmi-1/hTERT cell lines recapitulated primary cell morphology and ion transport function. The 2 F508del-CFTR cell lines responded robustly to CFTR modulators, which was mirrored in the parent primary cells and in the cell donors’ clinical response. Cereblon E3 ligase modulators targeting eukaryotic release factor 3a (eRF3a) rescued W1282X-CFTR function to approximately 20% of WT levels and, when paired with G418, rescued G542X-CFTR function to approximately 50% of WT levels. Intriguingly, eRF3a degraders also diminished epithelial sodium channel (ENaC) function. These studies demonstrate that Bmi-1/hTERT cell lines faithfully mirrored primary cell responses to CFTR modulators and illustrate a therapeutic approach to rescue CFTR nonsense mutations. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1558-8238 |
Relation: | https://doaj.org/toc/1558-8238 |
DOI: | 10.1172/JCI154571 |
Access URL: | https://doaj.org/article/0342006f024949bb976f55db34ef1e17 |
Accession Number: | edsdoj.0342006f024949bb976f55db34ef1e17 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://doaj.org/article/0342006f024949bb976f55db34ef1e17 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from Directory of Open Access Journals MouseOverText: View record from Directory of Open Access Journals – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=15588238&ISBN=&volume=132&issue=18&date=20220901&spage=&pages=&title=The Journal of Clinical Investigation&atitle=Small-molecule%20eRF3a%20degraders%20rescue%20CFTR%20nonsense%20mutations%20by%20promoting%20premature%20termination%20codon%20readthrough&aulast=Rhianna%20E.%20Lee&id=DOI:10.1172/JCI154571 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.0342006f024949bb976f55db34ef1e17 RelevancyScore: 947 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 947.154418945313 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rhianna+E%2E+Lee%22">Rhianna E. Lee</searchLink><br /><searchLink fieldCode="AR" term="%22Catherine+A%2E+Lewis%22">Catherine A. Lewis</searchLink><br /><searchLink fieldCode="AR" term="%22Lihua+He%22">Lihua He</searchLink><br /><searchLink fieldCode="AR" term="%22Emily+C%2E+Bulik-Sullivan%22">Emily C. Bulik-Sullivan</searchLink><br /><searchLink fieldCode="AR" term="%22Samuel+C%2E+Gallant%22">Samuel C. Gallant</searchLink><br /><searchLink fieldCode="AR" term="%22Teresa+M%2E+Mascenik%22">Teresa M. Mascenik</searchLink><br /><searchLink fieldCode="AR" term="%22Hong+Dang%22">Hong Dang</searchLink><br /><searchLink fieldCode="AR" term="%22Deborah+M%2E+Cholon%22">Deborah M. Cholon</searchLink><br /><searchLink fieldCode="AR" term="%22Martina+Gentzsch%22">Martina Gentzsch</searchLink><br /><searchLink fieldCode="AR" term="%22Lisa+C%2E+Morton%22">Lisa C. Morton</searchLink><br /><searchLink fieldCode="AR" term="%22John+T%2E+Minges%22">John T. Minges</searchLink><br /><searchLink fieldCode="AR" term="%22Jonathan+W%2E+Theile%22">Jonathan W. Theile</searchLink><br /><searchLink fieldCode="AR" term="%22Neil+A%2E+Castle%22">Neil A. Castle</searchLink><br /><searchLink fieldCode="AR" term="%22Michael+R%2E+Knowles%22">Michael R. Knowles</searchLink><br /><searchLink fieldCode="AR" term="%22Adam+J%2E+Kimple%22">Adam J. Kimple</searchLink><br /><searchLink fieldCode="AR" term="%22Scott+H%2E+Randell%22">Scott H. Randell</searchLink> – Name: TitleSource Label: Source Group: Src Data: The Journal of Clinical Investigation, Vol 132, Iss 18 (2022) – Name: Publisher Label: Publisher Information Group: PubInfo Data: American Society for Clinical Investigation, 2022. – Name: DatePubCY Label: Publication Year Group: Date Data: 2022 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Medicine – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Pulmonology%22">Pulmonology</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink> – Name: Abstract Label: Description Group: Ab Data: The vast majority of people with cystic fibrosis (CF) are now eligible for CF transmembrane regulator (CFTR) modulator therapy. The remaining individuals with CF harbor premature termination codons (PTCs) or rare CFTR variants with limited treatment options. Although the clinical modulator response can be reliably predicted using primary airway epithelial cells, primary cells carrying rare CFTR variants are scarce. To overcome this obstacle, cell lines can be created by overexpression of mouse Bmi-1 and human TERT (hTERT). Using this approach, we developed 2 non-CF and 6 CF airway epithelial cell lines, 3 of which were homozygous for the W1282X PTC variant. The Bmi-1/hTERT cell lines recapitulated primary cell morphology and ion transport function. The 2 F508del-CFTR cell lines responded robustly to CFTR modulators, which was mirrored in the parent primary cells and in the cell donors’ clinical response. Cereblon E3 ligase modulators targeting eukaryotic release factor 3a (eRF3a) rescued W1282X-CFTR function to approximately 20% of WT levels and, when paired with G418, rescued G542X-CFTR function to approximately 50% of WT levels. Intriguingly, eRF3a degraders also diminished epithelial sodium channel (ENaC) function. These studies demonstrate that Bmi-1/hTERT cell lines faithfully mirrored primary cell responses to CFTR modulators and illustrate a therapeutic approach to rescue CFTR nonsense mutations. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1558-8238 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://doaj.org/toc/1558-8238 – Name: DOI Label: DOI Group: ID Data: 10.1172/JCI154571 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/0342006f024949bb976f55db34ef1e17" linkWindow="_blank">https://doaj.org/article/0342006f024949bb976f55db34ef1e17</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.0342006f024949bb976f55db34ef1e17 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0342006f024949bb976f55db34ef1e17 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI154571 Languages: – Text: English Subjects: – SubjectFull: Pulmonology Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: Medicine Type: general Titles: – TitleFull: Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rhianna E. Lee – PersonEntity: Name: NameFull: Catherine A. Lewis – PersonEntity: Name: NameFull: Lihua He – PersonEntity: Name: NameFull: Emily C. Bulik-Sullivan – PersonEntity: Name: NameFull: Samuel C. Gallant – PersonEntity: Name: NameFull: Teresa M. Mascenik – PersonEntity: Name: NameFull: Hong Dang – PersonEntity: Name: NameFull: Deborah M. Cholon – PersonEntity: Name: NameFull: Martina Gentzsch – PersonEntity: Name: NameFull: Lisa C. Morton – PersonEntity: Name: NameFull: John T. Minges – PersonEntity: Name: NameFull: Jonathan W. Theile – PersonEntity: Name: NameFull: Neil A. Castle – PersonEntity: Name: NameFull: Michael R. Knowles – PersonEntity: Name: NameFull: Adam J. Kimple – PersonEntity: Name: NameFull: Scott H. Randell IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 15588238 Numbering: – Type: volume Value: 132 – Type: issue Value: 18 Titles: – TitleFull: The Journal of Clinical Investigation Type: main |
ResultId | 1 |